AMARIN CORP PLC\UK Inventory
AMARIN CORP PLC\UK (AMRN) had Inventory of $164.07 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryNet · last filed 2026-07-29
- 2026-06-30: Inventory, Net $164.07M.
- 2026-03-31: Inventory, Net $183.59M.
- 2025-12-31: Inventory, Net $195.91M.
- 2025-09-30: Inventory, Net $184.70M.
| Period end | Inventory, Net |
|---|---|
| 2026-06-30 | $164.07M 10-Q · filed 2026-07-29 |
| 2026-03-31 | $183.59M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $195.91M 10-Q · filed 2026-07-29 |
| 2025-09-30 | $184.70M 10-Q · filed 2025-10-29 |
| 2025-06-30 | $171.24M 10-Q · filed 2025-07-30 |
| 2025-03-31 | $159.49M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $166.05M 10-K · filed 2026-03-02 |
| 2024-09-30 | $224.00M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $239.41M 10-Q · filed 2024-07-31 |
| 2024-03-31 | $255.28M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $258.62M 10-K · filed 2025-03-12 |
| 2023-09-30 | $254.46M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $227.02M 10-Q · filed 2023-08-02 |
| 2023-03-31 | $225.81M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $228.73M 10-K · filed 2024-02-29 |
| 2022-09-30 | $227.61M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $225.77M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $267.82M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $234.68M 10-K · filed 2023-03-01 |
| 2021-09-30 | $309.27M 10-Q · filed 2021-11-03 |
| 2021-06-30 | $272.45M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $230.89M 10-Q · filed 2021-04-29 |
| 2020-12-31 | $188.86M 10-K · filed 2022-03-01 |
| 2020-09-30 | $148.53M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $124.84M 10-Q · filed 2020-08-04 |
| 2020-03-31 | $92.12M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $76.77M 10-K · filed 2021-02-25 |
| 2019-09-30 | $54.56M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $46.27M 10-Q · filed 2019-07-31 |
| 2019-03-31 | $57.91M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $57.80M 10-K · filed 2020-02-25 |
| 2018-09-30 | $43.67M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $40.09M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $35.10M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $30.26M 10-K · filed 2019-02-27 |
| 2017-09-30 | $28.55M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $24.81M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $23.88M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $20.51M 10-K · filed 2018-02-27 |
| 2016-09-30 | $19.77M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $20.31M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $21.34M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $18.98M 10-K · filed 2017-03-01 |
| 2015-09-30 | $19.70M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $20.50M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $16.18M 10-Q · filed 2015-05-08 |
| 2014-12-31 | $13.73M 10-K · filed 2016-02-25 |
| 2014-09-30 | $11.89M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $17.14M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $21.83M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $21.21M 10-K · filed 2015-03-03 |
| 2013-09-30 | $27.08M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $28.51M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $27.43M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $21.26M 10-K · filed 2014-02-27 |
| 2012-09-30 | $8.99M 10-Q · filed 2012-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |